Skip to content
Triangle logo TriangleGet started
← Chronic Myeloid Leukemia

HEALTH PROFESSIONAL · SOURCE READING

Allogeneic BMT or SCT

Source: Chronic Myeloid Leukemia Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: March 13, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Blastic-Phase CML / Treatment Options for Blastic-Phase CML

Allogeneic BMT or SCT should be considered when feasible, depending on response and durability of response.[8-12]

Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice